First Time Loading...
T

Triumph Science&Technology Co Ltd
SSE:600552

Watchlist Manager
Triumph Science&Technology Co Ltd
SSE:600552
Watchlist
Price: 10.95 CNY -3.52% Market Closed
Updated: May 4, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

10B
+2%
Assets
Growth Rates:
1 Year
+36%
3 Years
+33%
5 Years
+81%
7 Years
+126%
10 Years
+364%
5.9B
+3%
Liabilities
Growth Rates:
1 Year
+26%
3 Years
+18%
5 Years
+89%
7 Years
+177%
10 Years
+844%
4.1B
-0.1%
Equity
Growth Rates:
1 Year
+53%
3 Years
+62%
5 Years
+69%
7 Years
+79%
10 Years
+168%

Balance Sheet Decomposition
Triumph Science&Technology Co Ltd

10B
Assets
5.9B
Liabilities
10B
Assets
5.9B
Liabilities
Current Assets 5.7B
Cash & Short-Term Investments 1.4B
Receivables 1.9B
Other Current Assets 2.5B
Non-Current Assets 4.3B
PP&E 3.4B
Intangibles 757.2m
Other Non-Current Assets 54.8m
Current Liabilities 4B
Accounts Payable 842.7m
Accrued Liabilities 64.9m
Short-Term Debt 1.4B
Other Current Liabilities 1.7B
Non-Current Liabilities 1.8B
Long-Term Debt 1.3B
Other Non-Current Liabilities 550.5m

Balance Sheet
Triumph Science&Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
700
398
801
188
317
218
241
544
678
661
Cash
0
0
0
0
0
0
0
0
179
661
Cash Equivalents
700
398
801
188
317
218
241
544
499
0
Short-Term Investments
0
0
15
0
3
45
89
0
0
737
Total Receivables
482
637
1 063
1 366
1 403
1 526
1 841
1 808
1 876
1 563
Accounts Receivables
300
392
773
1 011
1 019
1 060
1 394
1 317
1 181
934
Other Receivables
182
246
291
355
384
467
447
492
695
629
Inventory
182
200
742
952
1 157
1 566
1 688
1 740
1 849
1 919
Other Current Assets
65
99
232
422
340
457
543
549
242
434
Total Current Assets
1 428
1 334
2 853
2 928
3 220
3 812
4 403
4 642
4 645
5 313
PP&E Net
629
959
1 204
1 370
1 459
1 631
1 935
2 221
3 097
3 515
PP&E Gross
629
959
1 204
1 370
1 459
1 631
1 935
2 221
3 097
3 515
Accumulated Depreciation
212
257
360
393
490
558
587
652
1 235
1 487
Intangible Assets
72
133
264
351
326
343
340
433
512
549
Goodwill
0
0
254
254
232
196
196
196
196
196
Long-Term Investments
2
2
2
0
0
0
0
0
0
0
Other Long-Term Assets
1
4
25
28
30
38
42
41
57
54
Other Assets
0
0
254
254
232
196
196
196
196
196
Total Assets
2 132
N/A
2 432
+14%
4 601
+89%
4 931
+7%
5 266
+7%
6 021
+14%
6 916
+15%
7 533
+9%
8 509
+13%
9 626
+13%
Liabilities
Accounts Payable
43
94
370
570
424
612
793
803
975
648
Accrued Liabilities
22
21
35
39
35
38
62
73
112
102
Short-Term Debt
319
471
1 562
1 237
1 293
1 649
2 157
2 311
1 952
1 208
Current Portion of Long-Term Debt
0
0
40
6
36
705
134
857
366
827
Other Current Liabilities
73
17
137
159
142
92
58
110
538
1 163
Total Current Liabilities
413
603
2 144
2 011
1 928
3 096
3 203
4 153
3 942
3 948
Long-Term Debt
40
40
7
297
683
219
889
477
1 043
1 108
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Minority Interest
15
17
104
132
159
186
229
277
293
385
Other Liabilities
49
62
84
133
126
117
104
92
99
103
Total Liabilities
516
N/A
722
+40%
2 339
+224%
2 573
+10%
2 896
+13%
3 618
+25%
4 426
+22%
4 999
+13%
5 376
+8%
5 544
+3%
Equity
Common Stock
239
359
384
384
767
764
764
764
764
945
Retained Earnings
316
410
521
597
636
679
767
811
485
549
Additional Paid In Capital
1 061
941
1 357
1 377
968
960
960
960
1 883
2 588
Total Equity
1 616
N/A
1 710
+6%
2 262
+32%
2 358
+4%
2 371
+1%
2 403
+1%
2 490
+4%
2 535
+2%
3 132
+24%
4 082
+30%
Total Liabilities & Equity
2 132
N/A
2 432
+14%
4 601
+89%
4 931
+7%
5 266
+7%
6 021
+14%
6 916
+15%
7 533
+9%
8 509
+13%
9 626
+13%
Shares Outstanding
Common Shares Outstanding
479
718
767
767
767
764
764
764
764
945

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.